Accelerating Implementation of Long-Acting Injectables
RWHAP Technical Assistance Provider updated on 06/11/2024
RWHAP Technical Assistance Provider updated on 06/11/2024
Blog updated 03/28/2024
Resource updated 08/17/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource from the RWHAP Best Practices Compilation updated on 04/15/2024
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Blog updated 02/28/2023
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 06/21/2024
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
The TargetHIV website is the central hub for RWHAP technical assistance (TA), with an audience of 40,000 unique users a year. Of these, approximately 25 percent access resources from data-related TA providers. This poster will describe how we collect and interpret website data to monitor and improve our dissemination approaches.
Resource (Conference Presentation) updated 09/14/2023
The syndemic of opioid use disorder, HCV and HIV and stigma causes burdens on individuals and the system. Integrating siloed systems of care is critical to addressing this crisis. Overlapping cascades of care are key to understanding the empirical relationships of these diseases and opportunities to identify, prevent and co-treat.
Resource (Conference Presentation) updated 09/14/2023